99% Savings - Buy Just @1 Rs X
Salbutamol + Ambroxol + Guaifenesin is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Salbutamol + Ambroxol + Guaifenesin is used -
Severe
Moderate
Mild
Common
Is the use of Salbutamol + Ambroxol + Guaifenesin safe for pregnant women?
Pregnant women may experience moderate side effects from Salbutamol + Ambroxol + Guaifenesin. It is best to stop taking Salbutamol + Ambroxol + Guaifenesin immediately and inform your doctor if you notice any discomfort.
Is the use of Salbutamol + Ambroxol + Guaifenesin safe during breastfeeding?
Breastfeeding women may feel side effects of Salbutamol + Ambroxol + Guaifenesin. If you see any side effects, stop taking Salbutamol + Ambroxol + Guaifenesin immediately and talk to your doctor. Take Salbutamol + Ambroxol + Guaifenesin again, only after your doctor's advice.
What is the effect of Salbutamol + Ambroxol + Guaifenesin on the Kidneys?
Salbutamol + Ambroxol + Guaifenesin does not damage the kidneys.
What is the effect of Salbutamol + Ambroxol + Guaifenesin on the Liver?
There are no any side effects of Salbutamol + Ambroxol + Guaifenesin on the liver.
What is the effect of Salbutamol + Ambroxol + Guaifenesin on the Heart?
Salbutamol + Ambroxol + Guaifenesin is not harmful for the heart.
Salbutamol + Ambroxol + Guaifenesin should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Salbutamol + Ambroxol + Guaifenesin unless your doctor advises you to do so -
Is this Salbutamol + Ambroxol + Guaifenesin habit forming or addictive?
No, you will not get addicted to Salbutamol + Ambroxol + Guaifenesin.
Interaction between Food and Salbutamol + Ambroxol + Guaifenesin
Taking Salbutamol + Ambroxol + Guaifenesin with food does not harm your health.
Interaction between Alcohol and Salbutamol + Ambroxol + Guaifenesin
Information about the interaction of Salbutamol + Ambroxol + Guaifenesin and alcohol is not currently available because this topic has not been researched yet.
Take Salbutamol + Ambroxol + Guaifenesin as long as you do not get complete symptomatic relief. Do not discontinue the drug suddenly or take it longer than prescribed by your doctor.
Yes, Salbutamol + Ambroxol + Guaifenesin is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as fast beating heart and dizziness. If you experience any discomfort after taking this medicine then inform your doctor immediately and follow his/her instructions.
Yes, Salbutamol + Ambroxol + Guaifenesin can cause an increase in sweating but it occurs only in a few cases. It is a known side effect of this drug. It occurs due to stimulation of sweat glands which causes increased release of sweat from these glands.
No, Salbutamol + Ambroxol + Guaifenesin does not cause nosebleed (epistaxis) at regular doses. If you are experiencing nose bleed after taking this drug, then please consult your doctor immediately without any further delay.
Yes, Salbutamol + Ambroxol + Guaifenesin causes dry mouth because it decreases the saliva secretion in your mouth. It is a common side effect of this drug. If you experience severe dry mouth after taking this drug, keep yourself hydrated with juices, shakes and ample water.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Proventil® HFA (albuterol sulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 118-120
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Guaifenesin
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 629-631